Belluscura was established in the U.K. as a medical device company focused on developing oxygen enrichment technology to help improve health for Chronic Obstructive Pulmonary Disease (COPD) patients and more favorable economic outcomes for the patient, provider, and insurance companies. COPD is the third leading cause of death in the United States, affecting approximately 30 million people in the U.S. and over 100 million worldwide. Belluscura, now with North American headquarters located in Texas, is dedicated to developing proprietary, patented oxygen enrichment technologies that can be applied across a range of treatment possibilities and positively impact millions of people across the globe.
View Top Employees from BelluscuraWebsite | https://www.belluscura.com |
Revenue | $1 million |
Employees | 32 (26 on RocketReach) |
Founded | 2015 |
Address | 15 Fetter Ln, London, Greater London EC4A 1BW, GB |
Phone | (214) 396-8313 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Industry | Manufacturing General, Medical Device, Manufacturing, Health Care |
Web Rank | 20 Million |
Keywords | Belluscura |
Competitors | Anaxsys Ltd, HAEMAIR LIMITED, Intermedical Limited, Quvium UK |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Belluscura employee's phone or email?
The Belluscura annual revenue was $1 million in 2023.
26 people are employed at Belluscura.
Belluscura is based in London, Greater London.
The NAICS codes for Belluscura are [32541, 325, 3254, 32].
The SIC codes for Belluscura are [28, 283].